VOYG Bears Up 14% in a Month as Stock Slumps 23%

Short positioning tells a clear story of conviction building into the slide. Short interest has climbed 14% over the past month to reach 20.2% of the free float, a high absolute level that ranks in the bottom 3rd percentile of the universe on ORTEX's short-score factor. The ORTEX short score itself has been running above 73 all week, well into elevated territory, though it has eased slightly from a peak near 75 in late September. Despite that concentration of bearish conviction, the borrow market is not under stress. Availability is near 57%, meaning roughly one share remains unborrowed for every two already lent out, and cost to borrow is only 0.81%, up 58% over the past month in absolute terms but still low in absolute terms. There is no squeeze dynamic here. The official FINRA fortnightly figure as of September 30 put short shares at 12.75 million with 3.4 days to cover, consistent with the daily estimate trend.

Options traders, unlike short sellers, have not turned defensive. The put/call ratio is at 0.21, barely above its 20-day average of 0.20, and well below the 52-week high of 0.77. By that measure, options positioning is almost exactly neutral and has been remarkably stable through the selloff. The contrast with the short book is notable: those with views are expressing them through the stock borrow market, not through puts.

The Street view is softening but not collapsing. TD Cowen cut its price target from $42 to $36 this week while holding a Buy rating, a signal that even bulls are acknowledging the stock has more work to do. The consensus mean target is $44.63, which implies significant upside from current levels, though that figure is anchored by older targets. Morgan Stanley downgraded to Underweight in July at a $39 target. Factor scores underscore the tension: EPS momentum over both 30 and 90 days ranks in the bottom decile (scores of 8), and the forward earnings yield is negative, reflecting a company still burning cash. The price-to-book multiple has compressed roughly 10% over the past month. The bull case rests on FY26 revenue guidance raised to $230-$255 million, a $5 billion-plus qualified pipeline, and the Starlab and Astrobotic platforms giving multi-year exposure to two growing markets. The bear case centres on 86% revenue dependence on US government and NASA, Starlab revenue not expected until late 2029 at the earliest, and ongoing dilution risk.

Ownership data adds a layer of nuance. BlackRock, the largest institutional holder at 6.1% of shares, added over one million shares in its most recent reported period ending September 30. State Street and Vanguard entities also added material positions in recent filings. That institutional accumulation runs counter to the short-side narrative, though it does not eliminate it. On the insider side, the most recent open-market activity on record was President Matthew Kuta selling over $8.5 million of stock in August, all under a 10b5-1 plan, meaning the trades were pre-arranged rather than discretionary signals. The net insider position over the past 90 days reported is minus 199,807 shares, though the bulk of that is the Kuta plan sales.

The next scheduled catalyst is earnings on November 2. Past reactions to prints have been dramatic: the August 2026 result produced a one-day move of 24% and a five-day gain of 53%. With the stock having given back most of that post-earnings gain in the weeks since, the November print will focus attention on whether the raised revenue guidance is tracking, how the Starlab procurement process is moving, and whether booking momentum from the record Q1 figure has sustained into Q3.